CANS.F Stock Overview
A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Willow Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.057 |
| 52 Week High | CA$0.10 |
| 52 Week Low | CA$0.051 |
| Beta | 1.14 |
| 11 Month Change | -17.08% |
| 3 Month Change | -19.30% |
| 1 Year Change | 3.24% |
| 33 Year Change | -83.39% |
| 5 Year Change | -87.68% |
| Change since IPO | -97.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| CANS.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0.5% | 4.0% | 2.2% |
| 1Y | 3.2% | 18.3% | 32.6% |
Return vs Industry: CANS.F underperformed the US Biotechs industry which returned 16.1% over the past year.
Return vs Market: CANS.F underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| CANS.F volatility | |
|---|---|
| CANS.F Average Weekly Movement | 16.6% |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CANS.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CANS.F's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 19 | Chris Savile | www.willowbio.com |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Willow Biosciences Inc. Fundamentals Summary
| CANS.F fundamental statistics | |
|---|---|
| Market cap | US$8.25m |
| Earnings (TTM) | -US$5.52m |
| Revenue (TTM) | US$2.05m |
4.0x
P/S Ratio-1.5x
P/E RatioIs CANS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CANS.F income statement (TTM) | |
|---|---|
| Revenue | CA$2.87m |
| Cost of Revenue | CA$4.94m |
| Gross Profit | -CA$2.07m |
| Other Expenses | CA$5.65m |
| Earnings | -CA$7.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.054 |
| Gross Margin | -72.15% |
| Net Profit Margin | -268.91% |
| Debt/Equity Ratio | 361.0% |
How did CANS.F perform over the long term?
See historical performance and comparison